EuBiologics wins green light for phase 1 trial of shingles vaccine
On Monday, EuBiologics announced that it obtained regulatory approval to initiate a phase 1 study for its proprietary herpes zoster vaccine, EuHZV. With the endorsement from the Ministry of Food and Drug Safety, the company's immune modulation …